Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary tuberculosis in children

J E Lowe, T M Daniel, C Richer

    The Journal of Thoracic and Cardiovascular Surgery
    |August 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tissue kallikrein is required for the cardioprotective effect of cyclosporin A in myocardial ischemia in the mouse.

    Biochemical pharmacology·2015
    Same author

    Pathophysiology of genetic deficiency in tissue kallikrein activity in mouse and man.

    Thrombosis and haemostasis·2013
    Same author

    Measurement of DNA damage and repair capacity as a function of age using the comet assay.

    Methods in molecular medicine·2012
    Same author

    Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice.

    Clinical and experimental pharmacology & physiology·2008
    Same author

    Murine models of myocardial and limb ischemia: diagnostic end-points and relevance to clinical problems.

    Vascular pharmacology·2006
    Same author

    Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemia.

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2005
    Same journal

    Bridging Pediatric and Young Adult Cancer Survivorship: Defining the Thoracic Surgeon's Role Across the Continuum.

    The Journal of thoracic and cardiovascular surgery·2026
    Same journal

    Beyond compensatory expansion: Extending 3-dimensional computed tomography volumetry toward lung-preserving local therapy.

    The Journal of thoracic and cardiovascular surgery·2026
    Same journal

    A CALL FOR STANDARDIZATION OF HYBRID ARCH FROZEN ELEPHANT TRUNK OUTCOMES REPORTING.

    The Journal of thoracic and cardiovascular surgery·2026
    Same journal

    Pediatric Mitral Valve Surgery: Current Practice from the European Congenital Heart Surgeons Association Congenital Database Analysis.

    The Journal of thoracic and cardiovascular surgery·2026
    Same journal

    Rethinking Failure to Rescue in Cardiac Surgery.

    The Journal of thoracic and cardiovascular surgery·2026
    Same journal

    Undersized Fontan conduits are not without risk.

    The Journal of thoracic and cardiovascular surgery·2026
    See all related articles

    Drug therapy effectively treats childhood pulmonary tuberculosis, significantly reducing the need for surgery. This medical approach is now the primary treatment for pediatric tuberculosis cases.

    Area of Science:

    • Pediatric Pulmonology
    • Infectious Diseases
    • Medical Management

    Background:

    • Pulmonary tuberculosis (TB) management has evolved significantly across all age groups.
    • Historically, surgical interventions played a more prominent role in treating pediatric TB.

    Observation:

    • A review of 140 children with confirmed pulmonary tuberculosis revealed a minimal need for surgical intervention.
    • Only 1.4% of cases required surgery: one for a large tuberculoma and another for chest wall involvement.

    Findings:

    • The vast majority (138 children) were successfully treated with anti-tuberculous drug therapy.
    • Pulmonary tuberculosis in children is predominantly a medical condition manageable with medication.

    Implications:

    Related Experiment Videos

    • This highlights the efficacy of current drug regimens for pediatric TB.
    • It underscores the shift towards non-surgical, medical management as the standard of care for childhood tuberculosis.